BIOMAT Database Logo BIOMAT Database Logo

[Immune deficiency during D-penicillamine treatment ]. 1977

F B Michel, and J Bousquet, and M Robinet-Levy, and P Mary

UI MeSH Term Description Entries
D007070 Immunoglobulin A Represents 15-20% of the human serum immunoglobulins, mostly as the 4-chain polymer in humans or dimer in other mammals. Secretory IgA (IMMUNOGLOBULIN A, SECRETORY) is the main immunoglobulin in secretions. IgA,IgA Antibody,IgA1,IgA2,Antibody, IgA
D010396 Penicillamine 3-Mercapto-D-valine. The most characteristic degradation product of the penicillin antibiotics. It is used as an antirheumatic and as a chelating agent in Wilson's disease. Dimethylcysteine,Mercaptovaline,beta,beta-Dimethylcysteine,Copper Penicillaminate,Cuprenil,Cuprimine,D-3-Mercaptovaline,D-Penicillamine,Metalcaptase,D 3 Mercaptovaline,D Penicillamine,Penicillaminate, Copper,beta,beta Dimethylcysteine
D002648 Child A person 6 to 12 years of age. An individual 2 to 5 years old is CHILD, PRESCHOOL. Children
D004406 Dysgammaglobulinemia An immunologic deficiency state characterized by selective deficiencies of one or more, but not all, classes of immunoglobulins. Dysgammaglobulinemias
D005260 Female Females
D006527 Hepatolenticular Degeneration A rare autosomal recessive disease characterized by the deposition of copper in the BRAIN; LIVER; CORNEA; and other organs. It is caused by defects in the ATP7B gene encoding copper-transporting ATPase 2 (EC 3.6.3.4), also known as the Wilson disease protein. The overload of copper inevitably leads to progressive liver and neurological dysfunction such as LIVER CIRRHOSIS; TREMOR; ATAXIA and intellectual deterioration. Hepatic dysfunction may precede neurologic dysfunction by several years. Cerebral Pseudosclerosis,Neurohepatic Degeneration,Pseudosclerosis,Wilson Disease,Copper Storage Disease,Hepatic Form of Wilson Disease,Hepato-Neurologic Wilson Disease,Hepatocerebral Degeneration,Hepatolenticular Degeneration Syndrome,Kinnier-Wilson Disease,Progressive Lenticular Degeneration,Westphal-Strumpell Syndrome,Wilson Disease, Hepatic Form,Wilson's Disease,Cerebral Pseudoscleroses,Copper Storage Diseases,Degeneration Syndrome, Hepatolenticular,Degeneration Syndromes, Hepatolenticular,Degeneration, Hepatocerebral,Degeneration, Hepatolenticular,Degeneration, Neurohepatic,Degeneration, Progressive Lenticular,Degenerations, Hepatocerebral,Degenerations, Neurohepatic,Disease, Copper Storage,Diseases, Copper Storage,Diseases, Hepato-Neurologic Wilson,Diseases, Kinnier-Wilson,Hepato Neurologic Wilson Disease,Hepato-Neurologic Wilson Diseases,Hepatocerebral Degenerations,Hepatolenticular Degeneration Syndromes,Kinnier Wilson Disease,Kinnier-Wilson Diseases,Lenticular Degeneration, Progressive,Neurohepatic Degenerations,Pseudoscleroses, Cerebral,Pseudosclerosis, Cerebral,Storage Disease, Copper,Storage Diseases, Copper,Syndrome, Hepatolenticular Degeneration,Syndromes, Hepatolenticular Degeneration,Westphal Strumpell Syndrome,Westphal-Strumpell Syndromes,Wilson Disease, Hepato-Neurologic,Wilson Diseases, Hepato-Neurologic,Wilsons Disease
D006801 Humans Members of the species Homo sapiens. Homo sapiens,Man (Taxonomy),Human,Man, Modern,Modern Man

Related Publications

F B Michel, and J Bousquet, and M Robinet-Levy, and P Mary
IgA deficiency during D-penicillamine treatment.
February 1977, British medical journal,
F B Michel, and J Bousquet, and M Robinet-Levy, and P Mary
[D-penicillamine-induced immune deficiency].
January 2000, Ryoikibetsu shokogun shirizu,
F B Michel, and J Bousquet, and M Robinet-Levy, and P Mary
IgA deficiency during penicillamine treatment.
March 1977, British medical journal,
F B Michel, and J Bousquet, and M Robinet-Levy, and P Mary
[Transient gynecomastia during treatment with D-penicillamine].
October 1984, Presse medicale (Paris, France : 1983),
F B Michel, and J Bousquet, and M Robinet-Levy, and P Mary
Observations during treatment of cystinuria with D-penicillamine.
May 1971, Acta medica Scandinavica,
F B Michel, and J Bousquet, and M Robinet-Levy, and P Mary
Hypocupremia-related hypochromic anemia during D-penicillamine treatment.
January 1982, Arthritis and rheumatism,
F B Michel, and J Bousquet, and M Robinet-Levy, and P Mary
Influence of D-penicillamine treatment on the humoral immune system.
January 1979, Scandinavian journal of rheumatology. Supplement,
F B Michel, and J Bousquet, and M Robinet-Levy, and P Mary
D-penicillamine and immune complex deposition.
August 1979, Annals of the rheumatic diseases,
F B Michel, and J Bousquet, and M Robinet-Levy, and P Mary
Progressive systemic sclerosis complicated with immune thrombocytopenia during D-penicillamine therapy.
February 1992, Internal medicine (Tokyo, Japan),
F B Michel, and J Bousquet, and M Robinet-Levy, and P Mary
[Myasthenia during treatment of rheumatoid polyarthritis with D-penicillamine].
January 1984, Therapie,
Copied contents to your clipboard!